About Bright Peak Therapeutics
Bright Peak Therapeutics is a private company based in Del Mar, California, incorporated in 2019 in Delaware. It has reported $196,500,002 raised in two offerings on Form D since June 2021. Its chief executive is Fredrik Wiklund.
Funding Rounds (SEC Form D)
| First sale | Filed with SEC | Amount sold | Investors | Avg. check | Terms | Filing |
|---|---|---|---|---|---|---|
| May 7, 2024 | Jun 11, 2024 | $89,999,991fully sold | 21 | $4.2M | EquityRule 506(b) | Form D ↗ |
| May 14, 2021 | Jun 11, 2021 | $106,500,011fully sold | 17 | $6.2M | EquityRule 506(b) | Form D ↗ |
| Total, two offerings | $196,500,002 | |||||
First sale is the date the first investor in the offering committed to invest. Companies must file Form D within 15 days of that date, so filing dates run later.
Leadership Team
Executive officers and directors listed on Bright Peak Therapeutics's Form D filed Jun 11, 2024.
BK
Bertolt Kreft
Executive officer
LS
Laura Shawver
Director
TW
Tom Woiwode
Director
VP
Vijaya Pattabiraman
Executive officer
MR
Matthew Robbins
Executive officer
LG
Leena Gandhi
Director
AX
Asish Xavier
Director
CS
Christine Siu
Director
FW
Fredrik Wiklund
Chief Executive Officer and director
EM
Emily Minkow
Director
JW
Jon Wigginton
Executive officer
JC
Jacob Chacko
Director
Earlier filings also listed Michael Rosenzweig (director, last listed Jun 2021), Josh Resnick (director, last listed Jun 2021) and Alexander Mayweg (director, last listed Jun 2021).